Marisa is Associate Professor in Health Economics and has joined the Imperial College Business School in 2008. She has been Associate Head of the Department of Management from 2016 -2018.
In the past she has held academic appointments at the Centre for Health Economics and the Department of Economics and Related Studies both at the University of York. Marisa holds a PhD in economics from York University, a MSc in Economics and Finance from Universitat Pompeu Fabra, a Master of Arts in Economics from Université Catholique de Louvain and a first degree in economics from Universidade Católica Portuguesa.
Marisa has a track record in leading multidisciplinary research in health economics and policy and collaboration with policy makers. Her expertise is on the economics and policy of healthcare innovation, the impact of policies on organisational performance and the behavioural determinants of decision making including health risky behaviour.
She is a fellow of Imperial College Data Science Institute and currently leads the Health Research stream at the Data Analytics Centre, as well as a Health Foundation funded research program on the determinants of the adoption of innovation for chronic conditions such as cancer, and cardiovascular disease. She is a member of the Health Parliament in Portugal.
She has developed and led the executive education Advanced Management Programme in Health Innovation. She is also passionate about diversity and has chaired the Gender Equity Committee at Imperial College Business School.
Recent public talks:
- World Economic Forum
- Where do we go from here? Leadership for Social Good
- Pay for Performance at Hospinnomics
- Harnessing Innovation for Global Health
Recent thought leadership articles and media coverage:
- How to make healthy eating easier
- Food solutions at Davos
- Can we build a culture of innovation in healthcare?
- How to give innovation a boost in healthcare
- Piloting a path for digital innovation
- New Homes for Old Drugs
Simmons B, Cooke G, Miraldo M, The impact of voluntary licences for hepatitis C on access to treatment: a difference-in-differences analysis, The Lancet Global Health, ISSN:2214-109X
et al., 2019, Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data, Journal of Health Economics, Vol:65, ISSN:0167-6296, Pages:153-169
et al., Modelling the impact of a food industry co-regulation agreement on Portugal’s non-communicable disease mortality, Bulletin of the World Health Organization, ISSN:0042-9686
Miraldo M, Lau K, Hauck K, 2019, Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England, Health Economics, Vol:28, ISSN:1057-9230, Pages:175-188
et al., 2019, Front-of-pack labelling policies and the need for guidance, Lancet Public Health, Vol:4, ISSN:2468-2667, Pages:E15-E15